Quest Diagnostics Inc
NYSE:DGX

Watchlist Manager
Quest Diagnostics Inc Logo
Quest Diagnostics Inc
NYSE:DGX
Watchlist
Price: 163.59 USD -0.18% Market Closed
Market Cap: 18.3B USD
Have any thoughts about
Quest Diagnostics Inc?
Write Note

Operating Margin
Quest Diagnostics Inc

13.9%
Current
17%
Average
4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
13.9%
=
Operating Profit
1.3B
/
Revenue
9.5B

Operating Margin Across Competitors

Country US
Market Cap 18.3B USD
Operating Margin
14%
Country US
Market Cap 91.8B USD
Operating Margin
4%
Country US
Market Cap 87.7B EUR
Operating Margin
4%
Country US
Market Cap 73B USD
Operating Margin
3%
Country DE
Market Cap 24.9B EUR
Operating Margin
7%
Country US
Market Cap 20.1B USD
Operating Margin
9%
Country DE
Market Cap 18.8B EUR
Operating Margin
7%
Country US
Market Cap 13.7B USD
Operating Margin
15%
Country DE
Market Cap 12.4B EUR
Operating Margin
7%
Country AU
Market Cap 13.4B AUD
Operating Margin
9%
Country US
Market Cap 8.6B USD
Operating Margin
17%
No Stocks Found

Quest Diagnostics Inc
Glance View

Market Cap
18.3B USD
Industry
Health Care

Quest Diagnostics Inc. is a leading provider of diagnostic testing and information services, playing a crucial role in the healthcare ecosystem. With a legacy dating back to the 1960s, Quest has established itself as a trusted partner for healthcare providers by offering a wide range of testing services, including routine blood tests, genetic testing, and specialized diagnostics for chronic diseases. The company's innovative approach to testing, bolstered by its extensive network of laboratories and state-of-the-art technology, ensures accurate and timely results, empowering patients and physicians alike to make informed healthcare decisions. As an industry leader, Quest not only aids in clinical decision-making but also plays a pivotal role in the ongoing shift toward value-based care, which emphasizes quality over quantity in patient treatment. For investors, Quest Diagnostics represents an attractive opportunity due to its strong financial performance and growth potential. The company benefits from a robust demand for diagnostic testing services, especially in the wake of the COVID-19 pandemic, which has heightened awareness of the importance of timely medical diagnostics. Quest's investment in cutting-edge technology and telehealth solutions positions it well to adapt to the evolving healthcare landscape. With a track record of consistent revenue growth and a commitment to returning value to shareholders through dividends and share buybacks, Quest Diagnostics stands out as a solid investment in the healthcare sector, blending stability with innovation in a critical industry.

DGX Intrinsic Value
147.89 USD
Overvaluation 10%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
13.9%
=
Operating Profit
1.3B
/
Revenue
9.5B
What is the Operating Margin of Quest Diagnostics Inc?

Based on Quest Diagnostics Inc's most recent financial statements, the company has Operating Margin of 13.9%.